Search - tctmd.com

Displaying 741 - 760 of 772

Sort: Relevancy | Date

Presentation TCT 2013

Efficacy and Safety of Balloon Pulmonary Angioplasty for Peripheral Type Chronic Thromboembolic Pulmonary Hypertension.

Presenter: Yu Taniguchi, Noriaki Emoto, Hiroto Kinutani, Hiromasa Otake, Toshiro Shinke, Junya Shite, Kenichi Hirata

January 31, 2013

Presentation TCT 2013

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Presenter: IMTIAZ KALYAR, James Gleeson, Sajjad Matiullah, Faisal Sharif

January 31, 2013

Presentation

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Presenter: Murray Esler

December 19, 2012

Presentation

Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension

Presenter: H. Mizoguchi

November 29, 2012

Presentation

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Presenter: Marc Dorenkamp

November 29, 2012

Presentation

Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

Presenter: M. Kataoka

November 14, 2012

Presentation TCT 2012

A 42-Year-Old Female with True Severe Resistant Hypertension

Presenter: Konstantinos Tsioufis

October 25, 2012

Presentation TCT 2012

PDA Closure in a Patient with Severe Pulmonary Hypertension

Presenter: Negar Salehi

October 25, 2012

Presentation TCT 2012

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Presenter: Deepak Bhatt

October 24, 2012

Presentation TCT 2012

Resistant Hypertension: Prevalence and Global Impact

Presenter: Stefan Bertog

October 24, 2012

Presentation TCT 2012

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

Physiologic Rationale for Interventional Therapies in Hypertension

Presenter: C. Venkata S. Ram

October 24, 2012

Presentation TCT 2012

Moderate Hypertension and ESRD

Presenter: Markus Schlaich

October 24, 2012

Presentation TCT 2012

Hypertension Therapies: A Word of Caution

Presenter: Peter Fitzgerald

October 24, 2012

Presentation TCT 2012

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

Presenter: Paul Sobotka

October 24, 2012

Presentation TCT 2012

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

Presenter: Christian Ukena

October 23, 2012

Presentation TCT 2012

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

Presenter: Felix Mahfoud

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Presenter: Alexander Plehn

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Advertisement

Efficacy and Safety of Balloon Pulmonary Angioplasty for Peripheral Type Chronic Thromboembolic Pulmonary Hypertension.

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

A 42-Year-Old Female with True Severe Resistant Hypertension

PDA Closure in a Patient with Severe Pulmonary Hypertension

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Resistant Hypertension: Prevalence and Global Impact

Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology

Physiologic Rationale for Interventional Therapies in Hypertension

Moderate Hypertension and ESRD

Hypertension Therapies: A Word of Caution

Beyond Hypertension: Future Prospects for Renal Denervation Therapy

TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension

TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the...

Hypertension: Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content